Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...
Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...
In response to this rising demand, the global market for glucose monitoring devices is projected to experience significant growth, with an anticipated compound annual growth rate (CAGR) of 10.6% over ...
A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biotronik ...
Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...